Coherus BioSciences Inc
F:8C5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Coherus BioSciences Inc
F:8C5
|
US |
|
PAR Technology Corp
NYSE:PAR
|
US |
|
E
|
Eni SpA
OTC:EIPAF
|
IT |
|
F
|
Fresenius Medical Care AG
DUS:FME
|
DE |
|
X
|
Xtb SA
WSE:XTB
|
PL |
|
S
|
Sirius XM Holdings Inc
DUS:RDO
|
US |
Wall St Price Targets
8C5 Price Targets Summary
Coherus BioSciences Inc
According to Wall Street analysts, the average 1-year price target for 8C5 is 7.255 EUR with a low forecast of 3.963 EUR and a high forecast of 12.361 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 8C5's stock price target?
Price Target
7.255
EUR
According to Wall Street analysts, the average 1-year price target for 8C5 is 7.255 EUR with a low forecast of 3.963 EUR and a high forecast of 12.361 EUR.
What is the Revenue forecast for Coherus BioSciences Inc?
Projected CAGR
65%
Over the last 12 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 3 years is 65%.
What is the Gross Profit forecast for Coherus BioSciences Inc?
Projected CAGR
70%
The compound annual growth rate for Gross Profit over the next 3 years is 70%.
